Key Market Driver
The availability of attractive reimbursement coverage is one of the important factors driving the global neurovascular devices market expansion. In the United States, for example, government agencies such as Medicare and Medicaid pay for healthcare through a diagnostic-related group (DRG) and ambulatory payment classification (APC) reimbursements. The majority of government and private-sector policies cover roughly 75% of the cost of devices and treatment. Private insurers, in addition to government insurers, will approve reimbursements for embolic protection devices. As a result, the market expansion will be fueled by advantageous reimbursement policies over the projection period.
Key Market Challenge
The availability of alternatives such as traditional endovascular surgical procedures, surgical clipping, stents, and flow diverters is one of the significant barriers to the global neurovascular devices market's growth. Endovascular prostheses called flow diverters are implanted in the aorta blood vessel to divert blood flow away from aneurysms. Even despite gradual thrombosis over time, these devices are successful in treating wide neck and gigantic aneurysms. As a result, the availability of a variety of neurovascular device alternatives may limit market growth over the projection period.
Download free sample for highlights on market Drivers & Challenges affecting the Neurovascular Devices market.
Company Profiles
The growing competition in the market is compelling vendors to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Some vendors are also adopting inorganic growth strategies such as M&As to remain competitive in the market.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
- Acandis GmbH
- Asahi Intecc Co. Ltd.
- BALT Group
- Cerus Endovascular Inc.
- Evasc Medical Systems Corp.
- Imperative Care
- Integer Holdings Corp.
- Integra LifeSciences Corp.
- Johnson and Johnson Inc.
- Kaneka Corp.
- Lepu Medical Technology (Beijing) Co. Ltd.
- Medtronic Plc
- MicroPort Scientific Corp.
Find additional highlights on the growth strategies adopted by vendors and their product offerings, Read Free Sample Report.
Competitive Analysis
The report includes the competitive analysis, a proprietary tool to analyze and evaluate the position of companies based on their industry position score and market performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Market Segmentation
The market is driven by the availability of favorable reimbursement coverage, outsourcing neurovascular devices research to CROs, and increasing the incidence of aneurysms. In addition, the availability of favorable reimbursement coverage is anticipated to boost the growth of the market as well.
The neurovascular devices market analysis includes the product segment and geographic landscape.
Technavio's neurovascular devices market is segmented as below:
- By Product
- Embolization devices
- Revascularization devices
- Embolic protection devices
- By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
Download free Sample Report to know additional highlights and key points on various market segments and their impact in coming years.
Related Reports
Hybrid Operating Room Market by Application and Geography - Forecast and Analysis 2022-2026
Image-Guided Therapy System Market by End-user and Geography - Forecast and Analysis 2022-2026
Neurovascular Devices Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.44% |
Market growth 2022-2026 |
$ 955.15 million |
Market structure |
Fragmented |
YoY growth (%) |
4.29 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 37% |
Key consumer countries |
US, Canada, Denmark, China, and India |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
Acandis GmbH, Asahi Intecc Co. Ltd., BALT Group, Cerus Endovascular Inc., Evasc Medical Systems Corp., Imperative Care, Integer Holdings Corp., Integra LifeSciences Corp., Johnson and Johnson Inc., Kaneka Corp., Lepu Medical Technology (Beijing) Co. Ltd., Medtronic Plc, MicroPort Scientific Corp., Penumbra Inc., Perflow Medical Ltd., phenox GmbH, Rapid Medical, SENSOME, Stryker Corp., and Terumo Corp. |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period, |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Product
- 5.1 Market segments
- Exhibit 24: Chart on Product - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
- 5.2 Comparison by Product
- Exhibit 26: Chart on Comparison by Product
- Exhibit 27: Data Table on Comparison by Product
- 5.3 Embolization devices - Market size and forecast 2021-2026
- Exhibit 28: Chart on Embolization devices - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Embolization devices - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Embolization devices - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Embolization devices - Year-over-year growth 2021-2026 (%)
- 5.4 Revascularization devices - Market size and forecast 2021-2026
- Exhibit 32: Chart on Revascularization devices - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Revascularization devices - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Revascularization devices - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Revascularization devices - Year-over-year growth 2021-2026 (%)
- 5.5 Embolic protection devices - Market size and forecast 2021-2026
- Exhibit 36: Chart on Embolic protection devices - Market size and forecast 2021-2026 ($ million)
- Exhibit 37: Data Table on Embolic protection devices - Market size and forecast 2021-2026 ($ million)
- Exhibit 38: Chart on Embolic protection devices - Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on Embolic protection devices - Year-over-year growth 2021-2026 (%)
- 5.6 Market opportunity by Product
- Exhibit 40: Market opportunity by Product ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 42: Chart on Market share by geography 2021-2026 (%)
- Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 44: Chart on Geographic comparison
- Exhibit 45: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 Denmark - Market size and forecast 2021-2026
- Exhibit 66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
- 7.9 China - Market size and forecast 2021-2026
- Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.10 Canada - Market size and forecast 2021-2026
- Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 7.11 India - Market size and forecast 2021-2026
- Exhibit 78: Chart on India - Market size and forecast 2021-2026 ($ million)
- Exhibit 79: Data Table on India - Market size and forecast 2021-2026 ($ million)
- Exhibit 80: Chart on India - Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on India - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 82: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.3 Impact of drivers and challenges
- Exhibit 83: Impact of drivers and challenges in 2021 and 2026
9 Vendor Landscape
- 9.2 Vendor landscape
- Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 85: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 86: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 87: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 88: Matrix on vendor position and classification
- 10.3 BALT Group
- Exhibit 89: BALT Group - Overview
- Exhibit 90: BALT Group - Business segments
- Exhibit 91: BALT Group - Key offerings
- Exhibit 92: BALT Group - Segment focus
- 10.4 Integer Holdings Corp.
- Exhibit 93: Integer Holdings Corp. - Overview
- Exhibit 94: Integer Holdings Corp. - Business segments
- Exhibit 95: Integer Holdings Corp. - Key offerings
- Exhibit 96: Integer Holdings Corp. - Segment focus
- 10.5 Integra LifeSciences Corp.
- Exhibit 97: Integra LifeSciences Corp. - Overview
- Exhibit 98: Integra LifeSciences Corp. - Business segments
- Exhibit 99: Integra LifeSciences Corp. - Key news
- Exhibit 100: Integra LifeSciences Corp. - Key offerings
- Exhibit 101: Integra LifeSciences Corp. - Segment focus
- 10.6 Johnson and Johnson Inc.
- Exhibit 102: Johnson and Johnson Inc. - Overview
- Exhibit 103: Johnson and Johnson Inc. - Business segments
- Exhibit 104: Johnson and Johnson Inc. - Key news
- Exhibit 105: Johnson and Johnson Inc. - Key offerings
- Exhibit 106: Johnson and Johnson Inc. - Segment focus
- 10.7 Kaneka Corp.
- Exhibit 107: Kaneka Corp. - Overview
- Exhibit 108: Kaneka Corp. - Business segments
- Exhibit 109: Kaneka Corp. - Key offerings
- Exhibit 110: Kaneka Corp. - Segment focus
- 10.8 Medtronic Plc
- Exhibit 111: Medtronic Plc - Overview
- Exhibit 112: Medtronic Plc - Business segments
- Exhibit 113: Medtronic Plc - Key news
- Exhibit 114: Medtronic Plc - Key offerings
- Exhibit 115: Medtronic Plc - Segment focus
- 10.9 MicroPort Scientific Corp.
- Exhibit 116: MicroPort Scientific Corp. - Overview
- Exhibit 117: MicroPort Scientific Corp. - Business segments
- Exhibit 118: MicroPort Scientific Corp. - Key offerings
- Exhibit 119: MicroPort Scientific Corp. - Segment focus
- 10.10 Penumbra Inc.
- Exhibit 120: Penumbra Inc. - Overview
- Exhibit 121: Penumbra Inc. - Key offerings
- 10.11 Stryker Corp.
- Exhibit 122: Stryker Corp. - Overview
- Exhibit 123: Stryker Corp. - Business segments
- Exhibit 124: Stryker Corp. - Key news
- Exhibit 125: Stryker Corp. - Key offerings
- Exhibit 126: Stryker Corp. - Segment focus
- 10.12 Terumo Corp.
- Exhibit 127: Terumo Corp. - Overview
- Exhibit 128: Terumo Corp. - Business segments
- Exhibit 129: Terumo Corp. - Key news
- Exhibit 130: Terumo Corp. - Key offerings
- Exhibit 131: Terumo Corp. - Segment focus
11 Appendix
- 11.2 Inclusions and exclusions checklist
- Exhibit 132: Inclusions checklist
- Exhibit 133: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 134: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 135: Research methodology
- Exhibit 136: Validation techniques employed for market sizing
- Exhibit 137: Information sources
- 11.5 List of abbreviations
- Exhibit 138: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article